Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 608Pancreatic Neoplasms 371Carcinoma, Hepatocellular 284Stomach Neoplasms 236Rectal Neoplasms 173Colonic Neoplasms 162Carcinoma, Non-Small-Cell Lung 160Esophageal Neoplasms 158Breast Neoplasms 138Neoplasms 126Neoplasm Metastasis 123Ovarian Neoplasms 114Lung Neoplasms 104Cholangiocarcinoma 101Liver Neoplasms 95Gastrointestinal Neoplasms 93Melanoma 82Biliary Tract Neoplasms 74Prostatic Neoplasms 71Esophageal Squamous Cell Carcinoma 66Endometrial Neoplasms 66Sarcoma 54Squamous Cell Carcinoma of Head and Neck 53Carcinoma, Renal Cell 53Uterine Cervical Neoplasms 47Adenocarcinoma Of Esophagus 45Head and Neck Neoplasms 44Urinary Bladder Neoplasms 39Triple Negative Breast Neoplasms 37Gastrointestinal Stromal Tumors 34

Interventions

S 1 (combination) 1Oxaliplatin 1Hyperthermic Intraperitoneal Chemotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Gastrointestinal × 90 days × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

NCT06597227 2026-04-27

TJHGC01

Tongji Hospital

Phase NA Recruiting
404 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡